MAS1 and COVID-19: As end-organ damage is an outcome of several COVID-19 patients and ACE2 regulates their development and physiology, as discussed below, the information can potentially help studies aiming to promote organ protection by modulating the ACE2/Ang1-7/Mas axis during disease, and studies that target ACE2 in therapeutic developments against both COVID-19 and heart disease.